<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">32104041</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1178-7015</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Clinical, cosmetic and investigational dermatology</Title>
          <ISOAbbreviation>Clin Cosmet Investig Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Classification and Staging of Morgellons Disease: Lessons from Syphilis.</ArticleTitle>
        <Pagination>
          <StartPage>145</StartPage>
          <EndPage>164</EndPage>
          <MedlinePgn>145-164</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2147/CCID.S239840</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Morgellons disease (MD) is a contested dermopathy that is associated with <i>Borrelia</i> spirochetal infection. A simple classification system was previously established to help validate the disease based on clinical features (classes I-IV).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Drawing on historical and pathological parallels with syphilis, we formulated a more detailed staging system based on clinical features as well as severity of skin lesions and corresponding histopathological infection patterns, as determined by anti-<i>Borrelia</i> immunohistochemical staining.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Clinical classes I-IV of MD are further categorized as mild, moderate and severe, or stages A, B and C, respectively, based on histopathological findings. Stage A lesions demonstrated little or no immune infiltrates and little or no disorganization of cells; macrophages were not present, and hemorrhage was negligible. Extracellular isolated spirochetes and intracellular staining of keratinocytes in the lower epidermis was occasionally seen. Stage C lesions demonstrated positive staining of keratinocytes in the stratum basale and stratum spinosum and positive intracellular staining of macrophages for <i>Borrelia</i>. Aggregate <i>Borrelia</i> colonies were frequently encountered, hemorrhage was frequent, and intracellularly stained fibroblasts were occasionally seen. Stage B lesions demonstrated a pattern intermediate between Stages A and C.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The enhanced staging system provides objective criteria to assess the severity of dermopathy in MD. Further studies are needed to determine the optimal treatment for MD based on this staging system related to <i>Borrelia</i> infection.</AbstractText>
          <CopyrightInformation>© 2020 Middelveen et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Middelveen</LastName>
            <ForeName>Marianne J</ForeName>
            <Initials>MJ</Initials>
            <Identifier Source="ORCID">0000-0001-5500-8315</Identifier>
            <AffiliationInfo>
              <Affiliation>Atkins Veterinary Services, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martinez</LastName>
            <ForeName>Roberto M</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>Martinez Veterinary Services, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fesler</LastName>
            <ForeName>Melissa C</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Union Square Medical Associates, San Francisco, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sapi</LastName>
            <ForeName>Eva</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology and Environmental Science, University of New Haven, West Haven, CT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burke</LastName>
            <ForeName>Jennie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Australian Biologics, Sydney, NSW, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shah</LastName>
            <ForeName>Jyotsna S</ForeName>
            <Initials>JS</Initials>
            <Identifier Source="ORCID">0000-0001-9890-366X</Identifier>
            <AffiliationInfo>
              <Affiliation>IGeneX Laboratories, Palo Alto, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nicolaus</LastName>
            <ForeName>Carsten</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0001-9094-4571</Identifier>
            <AffiliationInfo>
              <Affiliation>BCA-Clinic, Augsburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stricker</LastName>
            <ForeName>Raphael B</ForeName>
            <Initials>RB</Initials>
            <Identifier Source="ORCID">0000-0003-2149-8517</Identifier>
            <AffiliationInfo>
              <Affiliation>Union Square Medical Associates, San Francisco, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Cosmet Investig Dermatol</MedlineTA>
        <NlmUniqueID>101543449</NlmUniqueID>
        <ISSNLinking>1178-7015</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Borrelia burgdorferi</Keyword>
        <Keyword MajorTopicYN="N">Lyme disease</Keyword>
        <Keyword MajorTopicYN="N">Morgellons disease</Keyword>
        <Keyword MajorTopicYN="N">Treponema pallidum</Keyword>
        <Keyword MajorTopicYN="N">relapsing fever Borrelia</Keyword>
        <Keyword MajorTopicYN="N">syphilis</Keyword>
        <Keyword MajorTopicYN="N">tick-borne disease</Keyword>
      </KeywordList>
      <CoiStatement>Dr Jyotsna Shah is the President and stock owner of IGeneX Inc. Dr Raphael Stricker is the owner of Union Square Medical Associates. The authors report no other conflicts of interest in this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32104041</ArticleId>
        <ArticleId IdType="pmc">PMC7012249</ArticleId>
        <ArticleId IdType="doi">10.2147/CCID.S239840</ArticleId>
        <ArticleId IdType="pii">239840</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Savely G, Leitao MM. Skin lesions and crawling sensation: disease or delusion?
Adv Nurse Pract. 2005;13:16–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15898309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Savely VR, Leitao MM, Stricker RB. The mystery of Morgellons disease: infection or delusion?
Am J Clin Dermatol. 2006;7:1–5. doi:10.2165/00128071-200607010-00001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00128071-200607010-00001</ArticleId>
            <ArticleId IdType="pubmed">16489838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Savely VR, Stricker RB. Morgellons disease: the mystery unfolds. Exp Rev Dermatol. 2007;2(5):585–591. doi:10.1586/17469872.2.5.585</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/17469872.2.5.585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Savely VR, Stricker RB. Morgellons disease: analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. Clin Cosmet Investig Dermatol. 2010;3:67–78. doi:10.2147/ccid.s9520</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/ccid.s9520</ArticleId>
            <ArticleId IdType="pmc">PMC3047951</ArticleId>
            <ArticleId IdType="pubmed">21437061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Stricker RB. Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease. Clin Cosmet Investig Dermatol. 2011;4:167–177. doi:10.2147/CCID.S26183</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S26183</ArticleId>
            <ArticleId IdType="pmc">PMC3257881</ArticleId>
            <ArticleId IdType="pubmed">22253541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pearson ML, Selby JV, Katz KA; Unexplained Dermopathy Study Team, et al. Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. PLoS One. 2012;7:e29908. doi:10.1371/journal.pone.0029908</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0029908</ArticleId>
            <ArticleId IdType="pmc">PMC3266263</ArticleId>
            <ArticleId IdType="pubmed">22295070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah R, Taylor RE, Bewley A. Exploring the psychological profile of patients with delusional infestation. Acta Derm Venereol. 2017;97:98–101. doi:10.2340/00015555-2423</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2340/00015555-2423</ArticleId>
            <ArticleId IdType="pubmed">27026055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Stricker RB. Morgellons disease: a filamentous borrelial dermatitis. Int J Gen Med. 2016;9:349–354. doi:10.2147/IJGM.S116608</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJGM.S116608</ArticleId>
            <ArticleId IdType="pmc">PMC5072536</ArticleId>
            <ArticleId IdType="pubmed">27789971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Fesler MC, Stricker RB. History of Morgellons disease: from delusion to definition. Clin Cosmet Investig Dermatol. 2018;11:71–90. doi:10.2147/CCID.S152343</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S152343</ArticleId>
            <ArticleId IdType="pmc">PMC5811176</ArticleId>
            <ArticleId IdType="pubmed">29467580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freudenmann RW, Lepping P. Delusional infestation. Clin Microbiol Rev. 2009;22(4):690–732. doi:10.1128/CMR.00018-09</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00018-09</ArticleId>
            <ArticleId IdType="pmc">PMC2772366</ArticleId>
            <ArticleId IdType="pubmed">19822895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fesler MC, Middelveen MJ, Stricker RB. Clinical evaluation of Morgellons disease in a cohort of North American patients. Dermatol Rep. 2018;10:7660. doi:10.4081/dr.2018.7660</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/dr.2018.7660</ArticleId>
            <ArticleId IdType="pmc">PMC5941186</ArticleId>
            <ArticleId IdType="pubmed">29774138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Bandoski C, Burke J, et al. Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients. BMC Dermatol. 2015;15:1. doi:10.1186/s12895-015-0023-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12895-015-0023-0</ArticleId>
            <ArticleId IdType="pmc">PMC4328066</ArticleId>
            <ArticleId IdType="pubmed">25879673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Cruz ID, Fesler MC, Stricker RB, Shah JS. Detection of tick-borne infection in Morgellons disease patients by serological and molecular techniques. Clin Cosmet Investig Dermatol. 2018;11:561–569. doi:10.2147/CCID.S184521</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S184521</ArticleId>
            <ArticleId IdType="pmc">PMC6233863</ArticleId>
            <ArticleId IdType="pubmed">30519067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayne PJ. Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohort. Int J Gen Med. 2014;8:15–26. doi:10.2147/IJGM.S75825</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJGM.S75825</ArticleId>
            <ArticleId IdType="pmc">PMC4278782</ArticleId>
            <ArticleId IdType="pubmed">25565883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Filush KR, Bandoski C, et al. Mixed Borrelia burgdorferi and Helicobacter pylori biofilms in Morgellons disease dermatological specimens. Healthcare (Basel). 2019;7(2):E70. doi:10.3390/healthcare7020070</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/healthcare7020070</ArticleId>
            <ArticleId IdType="pmc">PMC6627092</ArticleId>
            <ArticleId IdType="pubmed">31108976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayne P, English JS, Kilbane EJ, et al. Morgellons: a novel dermatological perspective as the multisystem infective disease borreliosis. F1000Research. 2013;2:118. doi:10.12688/f1000research</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12688/f1000research</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Mayne PJ, Kahn DG, Stricker RB. Characterization and evolution of dermal filaments from patients with Morgellons disease. Clin Cosmet Investig Dermatol. 2013;6:1–21. doi:10.2147/CCID.S39017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S39017</ArticleId>
            <ArticleId IdType="pmc">PMC3544355</ArticleId>
            <ArticleId IdType="pubmed">23326202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Burugu D, Poruri A, et al. Association of spirochetal infection with Morgellons disease. F1000Res. 2013;2:25. doi:10.12688/f1000research.2-25.v1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12688/f1000research.2-25.v1</ArticleId>
            <ArticleId IdType="pmc">PMC3954163</ArticleId>
            <ArticleId IdType="pubmed">24715950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fredricks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch’s postulates. Clin Microbiol Rev. 1996;9(1):18–33. doi:10.1128/CMR.9.1.18</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.9.1.18</ArticleId>
            <ArticleId IdType="pmc">PMC172879</ArticleId>
            <ArticleId IdType="pubmed">8665474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Sapi E, Burke J, et al. Persistent Borrelia infection in patients with ongoing symptoms of Lyme disease. Healthcare (Basel). 2018;6(2):E33. doi:10.3390/healthcare6020033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/healthcare6020033</ArticleId>
            <ArticleId IdType="pmc">PMC6023324</ArticleId>
            <ArticleId IdType="pubmed">29662016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ekbom KA. Praeseniler dermat-zooenwahn. Acta Psychiatr Scand. 1938;13:227–259. doi:10.1111/j.1600-0447.1938.tb06569.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-0447.1938.tb06569.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vié J
L. ’idée délirante d’anthropathie interne. Poster presented at 39th Congress of Alienist Physicians and Neurologists of France, July 22–28, 1935; Brussels, Belgium.</Citation>
        </Reference>
        <Reference>
          <Citation>Allen L, Saylor-Hefley C.
Morgellons under investigation: identification of associated microorganisms by molecular analysis of epithelial samples; Proceedings of the 7th Annual Medical-Scientific Conference on Morgellons Disease; Austin, TX, USA
29–30
March
2014. 
Available from:
http://www.thecehf.org/resources/OSU%20_2015%20_Research.pdf. [Google Scholar]
Accessed November10, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Bandoski C.
Evidence for the presence of human pathogens Borrelia and Helicobacter in Morgellons patients’ skin samples; Proceedings of the 7th Annual Medical Scientific Conference on Morgellons Disease; Austin, TX, USA
29–30
March
2014. 
Available from: http://www.thecehf.org/cheryl-bandoski.html. [Google Scholar]
Accessed November10, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Lewis J, Lloyd VK, Robichaud GA.
Evidence of bacterial co-infections in Morgellons and Lyme patients; Proceedings of the 11th Annual Medical-Scientific Conference on Morgellons Disease; Austin, TX, USA
14–15
April
2017; Available from: http://www.thecehf.org/julie-lewis.html. [Google Scholar]
Accessed November10, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, Rasmussen EH, Kahn DG, Stricker RB. Morgellons disease: a chemical and light microscopic study. J Clin Exp Dermatol Res. 2012;3:2. doi:10.4172/2155-9554.1000140</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4172/2155-9554.1000140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindmeier C.
WHO releases new international classification of diseases (ICD 11), June
18, 2018. 
Available from: https://www.who.int/news-room/detail/18-06-2018-who-releases-new-international-classification-of-diseases-(icd-11). Accessed January18, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Conklin JE, Lieberman JV, Barnes CA, Louis DZ. Disease staging: implications for hospital reimbursement and management. Health Care Financ Rev. 1984;Suppl:13–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4195106</ArticleId>
            <ArticleId IdType="pubmed">10311073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middelveen MJ, McClain SA, Bandoski C, et al. Granulomatous hepatitis associated with chronic Borrelia burgdorferi infection: a case report. Res Open Access. 2014;1:875.</Citation>
        </Reference>
        <Reference>
          <Citation>Abcam Datasheet. Anti-borrelia burgdorferi antibody (ab20950), 2015. 
Available from: https://www.abcam.com/borrelia-burgdorferi-antibody-ab20950.html. Accessed November10, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Shah JS, Cruz DI, Narciso W, Lo W, Harris NS. Improved sensitivity of Lyme disease Western blots prepared with a mixture of Borrelia burgdorferi strains 297 and B31. Chronic Dis Int. 2014;1(2):7.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu S, Cruz ID, Ramos CC, Taleon P, Ramasamy R, Shah J. Pilot study of immunoblots with recombinant Borrelia burgdorferi antigens for laboratory diagnosis of Lyme disease. Healthcare (Basel). 2018;6(3):E99. doi:10.3390/healthcare6030099</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/healthcare6030099</ArticleId>
            <ArticleId IdType="pmc">PMC6163603</ArticleId>
            <ArticleId IdType="pubmed">30110913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Margos G, Hojgaard A, Lane RS, et al. Multilocus sequence analysis of Borrelia bissettii strains from North America reveals a new borrelia species, Borrelia kurtenbachii. Ticks Tick Borne Dis. 2010;1:151–158. doi:10.1016/j.ttbdis.2010.09.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ttbdis.2010.09.002</ArticleId>
            <ArticleId IdType="pmc">PMC3000690</ArticleId>
            <ArticleId IdType="pubmed">21157575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark KL, Leydet B, Hartman S. Lyme borreliosis in human patients in Florida and Georgia, USA. Int J Med Sci. 2013;10:915–931. doi:10.7150/ijms.6273</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijms.6273</ArticleId>
            <ArticleId IdType="pmc">PMC3675506</ArticleId>
            <ArticleId IdType="pubmed">23781138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Rourke M, Traweger A, Lusa L, et al. Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR. PLoS One. 2013;8:e63968. doi:10.1371/journal.pone.0063968</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0063968</ArticleId>
            <ArticleId IdType="pmc">PMC3655952</ArticleId>
            <ArticleId IdType="pubmed">23696863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayne PJ. Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue. Clin Cosmet Investig Dermatol. 2012;5:69–78. doi:10.2147/CCID.S31913</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S31913</ArticleId>
            <ArticleId IdType="pmc">PMC3426269</ArticleId>
            <ArticleId IdType="pubmed">22956879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CDC. Introduction to epidemiology, 2012. 
Available from: https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section5.html. Accessed November20, 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Baughn RE, Musher DM. Secondary syphilitic lesions. Clin Microbiol Rev. 2005;18(1):205–216. doi:10.1128/CMR.18.1.205-216.2005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.18.1.205-216.2005</ArticleId>
            <ArticleId IdType="pmc">PMC544174</ArticleId>
            <ArticleId IdType="pubmed">15653827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>French P. Syphilis. BMJ. 2007;334(7585):143–147. doi:10.1136/bmj.39085.518148.BE</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.39085.518148.BE</ArticleId>
            <ArticleId IdType="pmc">PMC1779891</ArticleId>
            <ArticleId IdType="pubmed">17235095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kannangara DW, Patel P. Report of non-Lyme, erythema migrans rashes from New Jersey with a review of possible role of tick salivary toxins. Vector Borne Zoonotic Dis. 2018;18(12):641–652. doi:10.1089/vbz.2018.2278</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/vbz.2018.2278</ArticleId>
            <ArticleId IdType="pubmed">30129909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Georgilis K, Peacock M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis. 1992;166(2):440–444. doi:10.1093/infdis/166.2.440</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/166.2.440</ArticleId>
            <ArticleId IdType="pubmed">1634816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klempner MS, Noring R, Rogers RA. Invasion of human skin fibroblasts by the Lyme disease spirochete. Borrelia Burgdorferi. J Infect Dis. 1993;167(5):1074–1081. doi:10.1093/infdis/167.5.1074</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/167.5.1074</ArticleId>
            <ArticleId IdType="pubmed">8486939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chmielewski T, Tylewska-Wierzbanowska S. Interactions between Borrelia burgdorferi and mouse fibroblasts. Pol J Microbiol. 2010;59(3):157–160. doi:10.33073/pjm-</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.33073/pjm-</ArticleId>
            <ArticleId IdType="pubmed">21033577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juanpere-Rodero N, Martin-Ezquerra G, Fernandez-Casado A, et al. Cell and tissue interactions of Treponema pallidum in primary and secondary syphilitic skin lesions: an ultrastructural study of serial sections. Ultrastruct Pathol. 2013;37(1):36–42. doi:10.3109/01913123.2011.584498</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/01913123.2011.584498</ArticleId>
            <ArticleId IdType="pubmed">21736426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sykes JA, Miller JN. Intracellular location of Treponema pallidum (Nichols strain) in the rabbit testis. Infect Immun. 1971;4(3):307–314. doi:10.1128/IAI.4.3.307-314.1971</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.4.3.307-314.1971</ArticleId>
            <ArticleId IdType="pmc">PMC416304</ArticleId>
            <ArticleId IdType="pubmed">4949494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sykes JA, Miller JN, Kalan AJ. Treponema pallidum within cells of a primary chancre from a human female. Br J Vener Dis. 1974;50(1):40–44. doi:10.1136/sti.50.1.40</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/sti.50.1.40</ArticleId>
            <ArticleId IdType="pmc">PMC1044973</ArticleId>
            <ArticleId IdType="pubmed">4593836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sykes JA, Kalan J. Intracellular Treponema pallidum in cells of a syphilitic lesion of the uterine cervix. Am J Obstet Gynecol. 1975;122(3):361–367. doi:10.1016/0002-9378(75)90185-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-9378(75)90185-4</ArticleId>
            <ArticleId IdType="pubmed">165724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inagaki S, Kimizuka R, Kokubu E, Saito A, Ishihara K. Treponema denticola invasion into human gingival epithelial cells. Microb Pathog. 2016;94:104–111. doi:10.1016/j.micpath.2016.01.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micpath.2016.01.010</ArticleId>
            <ArticleId IdType="pubmed">26806000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montgomery RR, Nathanson MH, Malawista SE. The fate of borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, Survival, Recovery. J Immunol.
1993;150(3):909–915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8423346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schröder JM. The role of keratinocytes in defense against infection. Curr Opin Infect Dis. 2010;23(2):106–110. doi:10.1097/QCO.0b013e328335b004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QCO.0b013e328335b004</ArticleId>
            <ArticleId IdType="pubmed">20010101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bigelmayr S, Koenigs A, Kraiczy P. Inter- and intraspecies-specific adhesion of Lyme borreliae to human keratinocytes. Ticks Tick Borne Dis. 2019;10(1):207–212. doi:10.1016/j.ttbdis.2018.10.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ttbdis.2018.10.006</ArticleId>
            <ArticleId IdType="pubmed">30391124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross EH. An intracellular parasite developing into spirochaetes, found by the jelly method of in vitro staining in syphilitic lesions and in the circulating blood during the secondary stages of the disease. Br Med J. 1912;2(2711):1651–1654. doi:10.1136/bmj.2.2711.1651</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.2.2711.1651</ArticleId>
            <ArticleId IdType="pmc">PMC2334605</ArticleId>
            <ArticleId IdType="pubmed">20766429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aberer E, Surtov-Pudar M, Wilfinger D, Deutsch A, Leitinger G, Schaider H. Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA. Arch Dermatol Res. 2018;310(2):117–126. doi:10.1007/s00403-017-1797-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00403-017-1797-1</ArticleId>
            <ArticleId IdType="pmc">PMC5811584</ArticleId>
            <ArticleId IdType="pubmed">29214350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Müller H, Eisendle K, Bräuninger W, Kutzner H, Cerroni L, Zelger B. Comparative analysis of immunohistochemistry, polymerase chain reaction and focus-floating microscopy for the detection of Treponema pallidum in mucocutaneous lesions of primary, secondary and tertiary syphilis. Br J Dermatol. 2011;165(1):50–60. doi:10.1111/j.1365-2133.2011.10314.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2133.2011.10314.x</ArticleId>
            <ArticleId IdType="pubmed">21410678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stricker RB, Johnson L. Lyme disease diagnosis and treatment: lessons from the AIDS epidemic. Minerva Med. 2010;101(6):419–425.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21196901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stricker RB, Johnson L. Lyme disease: the next decade. Infect Drug Resist. 2011;4:1–9. doi:10.2147/IDR.S15653</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IDR.S15653</ArticleId>
            <ArticleId IdType="pmc">PMC3108755</ArticleId>
            <ArticleId IdType="pubmed">21694904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cook MJ, Puri BK. Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy. Int J Gen Med. 2016;18(9):427–440. doi:10.2147/IJGM.S122313</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJGM.S122313</ArticleId>
            <ArticleId IdType="pmc">PMC5125990</ArticleId>
            <ArticleId IdType="pubmed">27920571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CDC. Lyme disease. Two tiered testing decision tree, 2011. 
Available from: https://www.cdc.gov/lyme/healthcare/clinician_twotier.html. Accessed January18, 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH Jr. Updates on Borrelia burgdorferi sensu lato complex with respect to public health. Ticks Tick Borne Dis. 2011;2(3):123–128. doi:10.1016/j.ttbdis.2011.04.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ttbdis.2011.04.002</ArticleId>
            <ArticleId IdType="pmc">PMC3167092</ArticleId>
            <ArticleId IdType="pubmed">21890064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fesler MC, Shah JS, Middelveen MJ, Burrascano JJ, Stricker RB. Lyme disease: diversity of Borrelia species in California and Mexico based on a novel immunoblot assay. J Invest Med. 2020;68:175-176.</Citation>
        </Reference>
        <Reference>
          <Citation>Forrester JD, Kjemtrup AM, Fritz CL, et al. Tickborne relapsing fever — United States, 1990–2011. MMWR. 2015;64:58–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4584558</ArticleId>
            <ArticleId IdType="pubmed">25632952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burkot TR, Mullen GR, Anderson R, Schneider BS, Happ CM, Zeidner NS. Borrelia lonestari DNA in adult Amblyomma americanum ticks, alabama. Emerg Infect Dis. 2001;7(3):471–473. doi:10.3201/eid0703.017323</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid0703.017323</ArticleId>
            <ArticleId IdType="pmc">PMC2631781</ArticleId>
            <ArticleId IdType="pubmed">11384533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bunikis J, Tsao J, Garpmo U, Berglund J, Fish D, Barbour AG. Typing of Borrelia relapsing fever group strains. Emerg Infect Dis. 2004;10(9):1661–1664. doi:10.3201/eid1009.040236</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1009.040236</ArticleId>
            <ArticleId IdType="pmc">PMC3320305</ArticleId>
            <ArticleId IdType="pubmed">15498172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwan TG, Raffel SJ, Schrumpf ME, et al. Tick-borne relapsing fever and Borrelia hermsii, Los Angeles County, California, USA. Emerg Infect Dis. 2009;15(7):1026–1031. doi:10.3201/eid1507.090223</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1507.090223</ArticleId>
            <ArticleId IdType="pmc">PMC2744237</ArticleId>
            <ArticleId IdType="pubmed">19624916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vuyyuru R, Liu H, Manser T, Alugupalli KR. Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever. Proc Natl Acad Sci U S A. 2011;108(51):20707–20712. doi:10.1073/pnas.1108776109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1108776109</ArticleId>
            <ArticleId IdType="pmc">PMC3251092</ArticleId>
            <ArticleId IdType="pubmed">22143787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cutler SJ. Relapsing fever borreliae: a global review. Clin Lab Med. 2015;35(4):847–865. doi:10.1016/j.cll.2015.07.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cll.2015.07.001</ArticleId>
            <ArticleId IdType="pubmed">26593261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wagemakers A, Staarink PJ, Sprong H, Hovius JW. Borrelia miyamotoi: a widespread tick-borne relapsing fever spirochete. Trends Parasitol. 2015;31(6):260–269. doi:10.1016/j.pt.2015.03.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pt.2015.03.008</ArticleId>
            <ArticleId IdType="pubmed">25892254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cutler SJ, Ruzic-Sabljic E, Potkonjak A. Emerging borreliae – expanding beyond Lyme borreliosis. Mol Cell Probes. 2017;31:22–27. doi:10.1016/j.mcp.2016.08.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mcp.2016.08.003</ArticleId>
            <ArticleId IdType="pubmed">27523487</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
